Mr. Chair, what I think has been important in the COVID-19 response, where we've seen a fierce, globally competitive market, is the benefits of having domestic supplies available to the jurisdictions. In a number of areas, we are now well situated, for example, with N95 respirators, with domestic manufacturing in Canada. We saw manufacturers leaning forward with the call from the federal government in terms of supports needed.
On February 28th, 2022. See this statement in context.